Sun Pharmaceutical Industries has launched Tedizolid Phosphate tablets 200 mg in India under the brand name STARIZO. STARIZO (Tedizolid Phosphate) is a novel, oxazolidinone-class antibacterial, used to treat Acute Bacterial Skin and Skin Structure Infection (ABSSSI).

Sun Pharma has obtained rights from Merck Sharp & Dohme Singapore Trading to develop, manufacture and commercialise Tedizolid Phosphate in India.

Powered by Capital Market – Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content